AvePoint Stock Down 47% as One Fund Slashes Stake by $65.9 Million

On February 17, 2026, Parsifal Capital Management disclosed it sold 4,770,561 shares of AvePoint (NASDAQ:AVPT), an estimated $65.90 million trade based on quarterly average pricing.

What happened

According to a February 17, 2026, SEC filing, Parsifal Capital Management sold 4,770,561 shares of AvePoint (NASDAQ:AVPT), with the estimated transaction value at $65.90 million based on the average closing price for the fourth quarter of 2025. The AvePoint position's value at quarter’s end was $52.12 million, down $75.81 million from the previous filing, a figure that includes both trading activity and price changes.

What else to know

• The sale reduced AvePoint to 4.27% of Parsifal Capital Management, LP's 13F AUM, from 9.68% previously.
• Top five holdings after the filing:
  • NYSE:SN: $134.27 million (13.5% of AUM)
  • NYSE:HGV: $110.78 million (11.2% of AUM)
  • NYSE:GMED: $106.76 million (10.8% of AUM)
  • NYSE:TEVA: $88.01 million (8.9% of AUM)
  • NYSE:GXO: $75.89 million (7.6% of AUM)
• As of February 17, 2026, AvePoint shares were priced at $10.41, down 46.9% over the past year and lagging the S&P 500 by 58.37 percentage points.

Company overview

Metric	Value
Revenue (TTM)	$393.99 million
Net income (TTM)	$1.97 million
Price (as of market close 2/17/26)	$10.41
One-year price change	(46.91%)

Company snapshot

• AvePoint offers Microsoft 365 data management solutions, including SaaS products for data protection, governance, and compliance across Microsoft 365, Dynamics 365, Salesforce, and Google Workspace.
• The firm generates revenue primarily through subscription-based software and cloud-hosted services focused on enterprise collaboration and data management.
• It targets enterprise customers and organizations with complex data governance and compliance needs, particularly those utilizing Microsoft cloud platforms.

AvePoint, Inc. is a technology company specializing in cloud-based data management and protection solutions for enterprise collaboration platforms. Its strategy centers on delivering scalable SaaS tools that enhance compliance, security, and productivity for organizations leveraging Microsoft 365 and other cloud ecosystems. The company leverages its expertise in data governance to address the evolving needs of large enterprises operating in regulated and data-intensive environments.

What this transaction means for investors

Cutting AvePoint from nearly 9.7% of assets to about 4.3% signals a meaningful reset, especially in a fund now anchored by names like SharkNinja, Hilton Grand Vacations, Globus Medical, Teva, and GXO. That lineup leans into consumer products, healthcare, and logistics. AvePoint, by contrast, is a pure cloud data governance play tied closely to Microsoft 365 ecosystems.

Operationally, the company doesn’t seem broken. Third quarter revenue climbed 24% year over year to $109.7 million, SaaS revenue jumped 38% to $84 million, and annual recurring revenue reached $390 million, up 26%.

Still, the stock’s 47% one-year decline shows investors have been cautious, and it’s worth pointing out that much of those declines have happened post-earnings after the past year. Ultimately, for long-term investors, the key question is AvePoint’s durability. Retention at 110% net and rising ARR point to stickiness. However, with the fund reallocating toward more diversified cash flow stories, it’s important to realize that sometimes movements are about risk calibration, especially in a volatile SaaS tape.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Globus Medical and SharkNinja. The Motley Fool recommends GXO Logistics. The Motley Fool has a disclosure policy.